Regeneron Pharmaceuticals
REGN
REGN
813 hedge funds and large institutions have $36.9B invested in Regeneron Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 198 funds opening new positions, 280 increasing their positions, 254 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 280 | Existing positions reduced: 254
1.6% more ownership
Funds ownership: 68.47% → 70.07% (+1.6%)
9% more call options, than puts
Call options by funds: $1.04B | Put options by funds: $959M
Holders
813
Holding in Top 10
22
Calls
$1.04B
Puts
$959M
Top Buyers
| 1 | +$2.56B | |
| 2 | +$233M | |
| 3 | +$224M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$209M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$106M |
Top Sellers
| 1 | -$1B | |
| 2 | -$586M | |
| 3 | -$288M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$182M |
| 5 |
HM
HealthCor Management
New York
|
-$140M |